Delete This Page Before You Submit

DELETE THIS PAGE BEFORE YOU SUBMIT

Specification for Symposium Description Abstract:

Full SyMPOSIUM title (Font: Arial, Size: 11, Case: All capitals, Alignment: Centred)

Symposium Author One1, Symposium Author Two2, etc. for all presenters in the symposium (Font: Arial, Size: 11, Alignment: Left, If authors have more than one affiliation/organisation then use superscripted numbers for affiliations after each author’s name, Name format: Initial(s), Surname)

1Author affiliations/organisations (Font: Arial, Size: 11, Alignment: Left, City in capitals, If more than one affiliation/organisation then use superscripted numbers for affiliations before each affiliation/organisation)

Establish the context, background and/or importance of the topic; indicate a problem, controversy or a gap in the field of research, and the primary purpose or focus of the symposium. Also outline the key focus of each of the presentations and/or discussion sessions in the symposium. (Font: Arial, Size: 11, Alignment: Justified)

CORRESPONDING AUTHOR: Contact details for the corresponding author ((Font: Arial, Size: 11, Alignment: Left, Format: Initial(s), Surname, Affiliation/organisation)

DISCUSSANT (if you have one): Contact details for the discussant ((Font: Arial, Size: 11, Alignment: Left, Format: Initial(s), Surname, Affiliation/organisation)

Word count: Provide a word count, not including title, authors’ names and affiliations or corresponding author details (Font: Arial, Size: 11, Alignment: Left, Maximum: 250 words)

You many want to look at the symposium abstracts from ICBM 2014 in Groningen to help you in preparing your own symposium abstracts for ICBM 2016 in Melbourne. The abstract booklet is availabe here:

http://link.springer.com/article/10.1007%2Fs12529-014-9418-2

DELETE THIS PAGE BEFORE YOU SUBMIT

Specfications for Individual Abstracts for Each Presenter (ONE ABSTRACT PER PAGE):

Full INDIVIDUAL ABSTRACT title (Font: Arial, Size: 11, Case: All capitals, Alignment: Centred)

Author One1, Author Two2, etc. (Font: Arial, Size: 11, Alignment: Left, If authors have more than one affiliation/organisation then use superscripted numbers for affiliations after each author’s name, Name format: Initial(s), Surname)

Introduction: Establish the context, background and/or importance of the topic; indicate a problem, controversy or a gap in the field of research, and the primary purpose of the research. (Font: Arial, Size: 11, Alignment: Justified)

Methods: Provide a description of the research design (qualitative or quantitative), data sources, subjects/participants, data collection and analysis. (Font: Arial, Size: 11, Alignment: Justified )

Results: Provide a summary and discussion of the results. (Font: Arial, Size: 11, Alignment: Justified)

Conclusions: A statement of the study’s conclusions and/or implication of the results (Font: Arial, Size: 11, Alignment: Justified)

CORRESPONDING AUTHOR: Contact details for the corresponding author ((Font: Arial, Size: 11, Alignment: Left, Format: Initial(s), Surname, Affiliation/organisation)

Word count: Provde a word count, not including title, authors’ names and affiliations or corresponding author details (Font: Arial, Size: 11, Alignment: Left, Maximum: 250 words)

Symposium Abstract Example/Template (REPLACE THE TEXT IN THE EXAMPLES WITH YOUR OWN AND DELETE THIS LINE BEFORE YOU SUBMIT):

Symposium description ABSTRACT:

INTERVENTIONS ADDRESSING THE PSYCHOLOGICAL CONCERNS AND NEEDS OF WOMEN IN THE BREAST CANCER CONTEXT

K. Sherman1, P. Butow2, E. Bleiker3, L. Cameron4

1Centre for Emotional Health, SYDNEY, Australia

2Psycho-Oncology Co-operative Research Group (POCOG), University of Sydney, SYDNEY, Australia

3Netherlands Cancer Institute, AMSTERDAM, Nederland

4University of California, MERCED, United States of America

Breast cancer presents individuals with challenges onmany levels.Women recently diagnosed with breast cancer face difficult decisions about treatment, particularly which type of surgery to choose. Following the active treatment phase, many women experience constant doubts about remaining cancer free. Another aspect that presents a number of psychological and emotional challenges to women in the breast cancer context is the process of undergoing genetic risk assessment for breast cancer susceptibility. The aim of this symposium is to present results of randomised controlled trials of three psychosocial interventions designed to enhance the psychological wellbeing of women undergoing genetic testing or faced with a diagnosis of breast cancer. The first intervention, BRECONDA, a web-based interactive decision aid is designed to facilitate decision making in women considering breast reconstruction following mastectomy. Results indicate high levels of user acceptability and patient benefits regarding the quality of the overall decisional process. The second 5-session intervention focuses on helping cancer survivors conquer fears of cancer recurrence. Findings from the trial indicate a high level of acceptability to both patients and therapists alike and potential benefits of decreased psychological morbidity. The final intervention addresses psychosocial issues that arise in women who undergo genetic risk assessment through the use of a Psychosocial Aspects of Hereditary Cancer questionnaire in the genetic counselling sessions. Findings indicate that the questionnaire led to increased discussion of problems in the counselling session, increased wellbeing and decreased general distress of women undergoing genetic risk assessment. Implications of these intervention approaches will be discussed.

CORRESPONDING AUTHOR: Associate Prof. K. Sherman, Centre for Emotional Health, Australia,

DISCUSSANT: Prof. L. Cameron, University of California, MERCED, United States of America,

Word count: 248

PRESENTER 1 INDIVIDUAL ABSTRACT:

THE BRECONDA TRIAL: FACILITATING SURGICAL DECISION MAKING OF WOMEN WITH BREAST CANCER

K. Sherman1, D. Harcourt2, L-K. Shaw1, C. Winch3, P. Brown4, L. Cameron4, T. Lam3, J. Boyages3

1Centre for Emotional Health, SYDNEY, Australia

2Centre for Appearance Research, University of the West of England, BRISTOL, United Kingdom

3Macquarie University Cancer Institute, SYDNEY, Australia

4University of California, MERCED, United States of America

Introduction: Women requiring mastectomy for breast cancer are faced with the difficult preference-based decision regarding whether, and how, to restore breast shape after surgery. We have developed a web-based decision aid, BRECONDA, to assist with this decision-making. In a randomised controlled trial we compared the efficacy of BRECONDA

with a general educational pamphlet.

Methods: Women diagnosed with breast cancer recruited into the multicentre web-based trial completed baseline questionnaires and were then randomly assigned into either: 1) Intervention (INT) – received unlimited access to BRECONDA and an electronic information booklet about breast reconstruction; or, 2) Control (CONT) - received the information booklet alone. Participants then completed 1- and 6-month follow-up questionnaires assessing satisfaction with information, decisional conflict and knowledge. INT participants completed ratings of perceived usefulness of the intervention and appropriateness of the content.

Results: Mixed method analyses (random intercept, maximum likelihood) demonstrated that INT participants reported lower decisional conflict at 1-(INT=27.3; CONT=35.5) and 6-(INT=23.7; CONT=30.9, p=.014) month follow-up, and greater satisfaction with information (1-month: INT=3.7, CONT=3.4; 6-months: INT=3.9, CONT=3.6, p=.005). INT participants indicated high to very high overall satisfaction with the intervention (78%), reporting that it was easy to use (75%), presented a balanced view (74%) and that the amount of information was “just right”(77%).

Conclusions: These findings indicate that intervention participants benefitted regarding their overall decisional process quality with greater satisfaction with information, lower decisional conflict and high user acceptability of the intervention, supporting the feasibility and acceptability of implementing BRECONDA into oncological surgery practice.

CORRESPONDING AUTHOR: Associate Prof. K. Sherman, Centre for Emotional, Health, Australia

Word count: 245

CONTINUE ADDING ADDITIONAL INDIVIDUAL ABSTRACTS ON THE NEXT PAGES FOR AS MANY PRESENTERS AS YOU INTEND TO HAVE. TYPICALLY SYMPOSIA HAVE A MAXIMUM OF 4 PRESENTERS, OR 3 PRESENTERS AND A DISCUSSANT. DELETE THIS TEXT BEFORE YOU SUBMIT.

PRESENTER 2 INDIVIDUAL ABSTRACT:

COPY AND PASTE THE INDIVIDUAL ASTRACT EXAMPLE HERE, THEN REPLACE THE EXAMPLE TEXT WITH YOUR OWN. DELETE THIS TEXT.

PRESENTER 3 INDIVIDUAL ABSTRACT:

COPY AND PASTE THE INDIVIDUAL ASTRACT EXAMPLE HERE, THEN REPLACE THE EXAMPLE TEXT WITH YOUR OWN. DELETE THIS TEXT.